Skip to main content
SpringerLink
Log in

Chemoembolizations and Hepatic Intra-arterial Chemotherapies

  • Chapter
  • First Online:
Embolization

  • 1308 Accesses

Abstract

Intra-arterial chemoembolization allows the administration of embolic agents and/or drugs to treat arterialized liver tumors, thus reducing the systemic side effects and sparing the disease-free liver parenchyma. Various techniques can be performed: transarterial embolization (TAE), transarterial chemo-infusion (TACI) with a high concentration of chemotherapy agents and minimal embolization, transarterial chemoembolization (TACE), and chemoembolization with drug-eluting beads (DEB TACE). Irradiation techniques are also therapeutic alternatives such as radioembolization with yttrium 90 and injection of radioactive Lipiodol (I 131): these highly specialized techniques are at the crossroads of interventional radiology, nuclear medicine, and radiotherapy, thus will not be developed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bruix J, Sherman M. Practice guidelines committee, American Association for the Study of Liver Diseases Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.

    Article  PubMed  Google Scholar 

  2. Bruix J, Sherman M. Management of hepato cellular carcinoma: an update AASLD practice guidelines. Hepatology. 2010;53:1–34.

    Article  Google Scholar 

  3. Grieco A, Pompili M, Caminit G, et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma under-going non-surgical therapy: comparison of Okuda, CLIP, and BCLC straging systems in a single Italian centre. Gut. 2005;54:411–8.

    Article  PubMed  CAS  Google Scholar 

  4. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma the BCLC staging classification. Semin Liver Dis. 1999;19:329–38.

    Article  PubMed  CAS  Google Scholar 

  5. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol. 2005;40(3):225–35.

    Article  PubMed  Google Scholar 

  6. Mazzafero V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepato cellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–9.

    Article  Google Scholar 

  7. Liapi E, Geschwind JF. Intra-arterial therapies for hepatocellular carcinoma: where do we stand? Ann Surg Oncol. 2010;17:1234–46.

    Article  PubMed  Google Scholar 

  8. Basile A, Carrafiello G, Ierardi AM, Tsetis D, Brountzos E. Quality-improvement guidelines for hepatic transarterial chemoembolization. Cardiovasc Intervent Radiol. 2012;35:765–74.

    Article  PubMed  Google Scholar 

  9. Bouvier A, Ozenne V, Aubé C, et al. Transarterial chemoembolisation: effect of selectivity on tolerance, tumour response and survival. Eur Radiol. 2011;21:1719–26.

    Article  PubMed  Google Scholar 

  10. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J, EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421–30.

    Article  PubMed  CAS  Google Scholar 

  11. Chua CT, Liauw W, Saxena A. Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma. Liver Int. 2010;30:166–74.

    Article  PubMed  Google Scholar 

  12. Gerunda GE, Neri D, Merenda R, et al. Role of transarterial chemoembolization before liver resection for hepatocarcinoma. Liver Transpl. 2000;6:619–26.

    Article  PubMed  CAS  Google Scholar 

  13. Wu CC, Ho YZ, Ho WL, et al. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg. 1995;82:122–6.

    Article  PubMed  CAS  Google Scholar 

  14. Yamasaki S, Hasegawa H, Kinoshita H, et al. A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res. 1996;87:206–11.

    Article  PubMed  CAS  Google Scholar 

  15. Cherqui D, Piedbois P, Pierga JY, et al. Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study. Cancer. 1994;73:2721–6.

    Article  PubMed  CAS  Google Scholar 

  16. Shimoda M, Bando T, Nagata T, et al. Prophylactic chemolipiodolization for postoperative hepatoma patients. Hepatogastroenterology. 2001;48:493–7.

    PubMed  CAS  Google Scholar 

  17. Lau WY, Leung TW, Ho SK, et al. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet. 1999;353:797–801.

    Article  PubMed  CAS  Google Scholar 

  18. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.

    Article  PubMed  Google Scholar 

  19. Groupe d’Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 1995;332:1256–61.

    Article  Google Scholar 

  20. Camma C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology. 2002;224:47–54.

    Article  PubMed  Google Scholar 

  21. Llovet JM, Bruix J. A systematic review of randomized trials for unresectable hepatocellular carcinoma chemoembolization improves survival. Hepatology. 2003;37:429–42.

    Article  PubMed  CAS  Google Scholar 

  22. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–71.

    Article  PubMed  CAS  Google Scholar 

  23. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–9.

    Article  PubMed  Google Scholar 

  24. Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004;10:115–20.

    Article  Google Scholar 

  25. Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010;33:41–52.

    Article  PubMed  Google Scholar 

  26. Chu QD, Hill HC, Douglass HO, et al. Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas. Ann Surg Oncol. 2002;9:855–62.

    Article  PubMed  Google Scholar 

  27. Salman HS, Cynamon J, Jagust M, et al. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver. Clin Colorectal Cancer. 2002;2:173–9.

    Article  PubMed  CAS  Google Scholar 

Suggested Reading

  • Basile A, Carrafiello G, Ierardi AM, Tsetis D, Brountzos E. Quality-improvement guidelines for hepatic transarterial chemoembolization. Cardiovasc Intervent Radiol. 2012;35:765–74.

    Article  PubMed  Google Scholar 

  • Bruix J, Sherman M. Management of hepatocellular carcinoma: an update – AASLD practice guidelines. Hepatology. 2010;53:1–34.

    Article  Google Scholar 

  • Cleveland TJ, Kelekis AD, Kopp C, et al. CIRSE take force on clinical pratice: Hepato Cellular Carinoma. In: Clinical practice in interventional radiology CIRSE, Vienna 2007. p. 74–9.

    Google Scholar 

  • Liapi E, Geschwind JF. Intra-arterial therapies for hepatocellular carcinoma: where do we stand? Ann Surg Oncol. 2010;17:1234–46.

    Article  PubMed  Google Scholar 

  • Liapi E, Geschwind JF. Transcatheter arterial chemo embolization for liver cancer: is it time to distinguish conventional from drug eluting chemoembolization? Cardiovasc Intervent Radiol. 2011;34:37–49.

    Article  PubMed  Google Scholar 

  • Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol. 2005;40(3):225–35.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France

    Pascal Chabrot MD, PhD, Agaïcha Alfidja Lankoande MD, Eric Dumousset MD & Louis Boyer MD, PhD

  2. Department of Hepatogastroenterology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France

    Armand Abergel MD, PhD

  3. Department of Abdominal Surgery, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France

    Denis Pezet MD, PhD

Authors
  1. Pascal Chabrot MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Agaïcha Alfidja Lankoande MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eric Dumousset MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Armand Abergel MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Denis Pezet MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Louis Boyer MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Louis Boyer MD, PhD .

Editor information

Editors and Affiliations

  1. Department of Radiology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France

    Pascal Chabrot

  2. Department of Radiology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France

    Louis Boyer

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Chabrot, P., Lankoande, A.A., Dumousset, E., Abergel, A., Pezet, D., Boyer, L. (2014). Chemoembolizations and Hepatic Intra-arterial Chemotherapies. In: Chabrot, P., Boyer, L. (eds) Embolization. Springer, London. https://doi.org/10.1007/978-1-4471-5182-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-5182-1_7

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-5181-4

  • Online ISBN: 978-1-4471-5182-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation